tiprankstipranks
Atara Biotherapeutics Inc (ATRA)
NASDAQ:ATRA
US Market
ATRA
Atara Biotherapeutics
RESEARCH TOOLSreports
Want to see ATRA full AI Analyst Report?

Atara Biotherapeutics (ATRA) Income Statement

1,201 Followers

Atara Biotherapeutics Income Statement

Last quarter (Q4 2025), Atara Biotherapeutics's total revenue was $1.59M, a decrease of -95.13% from the same quarter last year. In Q4, Atara Biotherapeutics's net income was $-3.41M. See Atara Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 120.77M$ 128.94M$ 8.57M$ 63.57M$ 20.34M
Gross Profit
$ 99.56M$ 107.93M$ -313.00K$ 63.57M$ -261.66M
Operating Expenses
$ 63.70M$ 191.37M$ 275.69M$ 344.09M$ 78.80M
Depreciation and Amortization
$ 640.00K$ 5.05M$ 4.83M$ 5.65M$ 9.35M
EBITDA
$ 50.41M$ -75.75M$ -266.00M$ -222.26M$ -331.12M
Operating Income
$ 35.86M$ -83.44M$ -276.01M$ -280.51M$ -340.46M
Other Income/Expenses
$ -3.14M$ -1.98M$ -105.00K$ 52.22M$ 367.00K
Pretax Income
$ 32.72M$ -85.42M$ -276.11M$ -228.29M$ -340.10M
Net Income
$ 32.69M$ -85.40M$ -276.13M$ -228.30M$ -340.14M
Per Share Metrics
Basic EPS
$ 2.61$ -11.41$ -65.18$ -55.96$ -90.78
Diluted EPS
$ 2.57$ -11.41$ -65.18$ -55.96$ -90.78
Weighted Average Shares Outstanding
 12.54M 7.49M 4.24M 4.08M 3.75M
Weighted Average Shares Outstanding (Diluted)
 12.72M 7.49M 4.24M 4.08M 3.75M
Currency in USD

Atara Biotherapeutics Earnings and Revenue History